logo
  • Home
  • News
Menu

Imago BioSciences Seeks $105 Million IPO

Home / Stock Analysis / Imago BioSciences Seeks $105 Million IPO
Article feature image

Imago BioSciences Seeks $105 Million IPO

13 Jul Stock Analysis

Andrew Brookes/Cultura via Getty Images
Quick Take
Imago BioSciences (IMGO) has filed to raise $105 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a clinical stage biopharma developing treatments for bone…

Click here to view the original article.

Tags:
Global, Seeking Alpha
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186808281.jpeg
+

Dolphin Entertainment, Inc. (NASDAQ:DLPN) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

20 Sep Stock Analysis
2022050900000223bd23dc9385b.jpg
+

Rongchang Bio’s stock price surged as the Phase III clinical trial of Telitacicept for gMG in China was selected for an oral presentation at the 2025 AANEM.

20 Sep Stock Analysis

recent post

  • shiba-inu-shib1-10.png

    Remittix Surges Up Crypto Rankings To

    Sep 20 2025
  • image1-1323.jpg

    ADA Shows Growth Signs, Still Leaving

    Sep 20 2025
  • 1585186808281.jpeg

    Dolphin Entertainment, Inc. (NASDAQ:DLPN) Stock Catapults

    Sep 20 2025
  • remittix-8.webp.webp

    How Remittix Has Become The Best

    Sep 20 2025
  • image3-1122.jpg

    Which Presale Has More Millionaire Potential

    Sep 20 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.